Book Value per Share: Vincerx Pharma Inc. (VINC)

Public company logo of Vincerx Pharma, Inc. (VINC)

Vincerx Pharma, Inc. (VINC) is facing a liquidity shortage and the depletion of reserves due to R&D costs. The net book value per share, illustrated by this chart from the GURU.Markets platform, shows that the indicator value reaches 0.40. Vincerx Pharma, Inc. (VINC) aims to expand its VIP platform into hemato-oncology therapy, although success depends on patent protection and securing partners to bring products to market.

Vincerx (VINC) - Accounting Value per Share from 07/04/2022 to 05/31/2025

Summary analytical data breakdowns for Vincerx Pharma Inc. (VINC)

- price and consensus price forecast:
Price Chart Vincerx|VINC - Broker Consensus Forecast
- market capitalization data:
Market Capitalization Vincerx Pharma, Inc.|VINC - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Vincerx Pharma|VINC - Company Net Assets|Market Capitalization to Book Value Ratio vincerx.com|VINC - Company Total Assets
- debt and liquidity data:
Debt to Equity Vincerx Pharma, Inc.|VINC - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Vincerx|VINC - Company Total Debt|Debts to Book Capitalization Vincerx Pharma, Inc.|VINC - Long-Term Debt|Company Short-Term Debt Vincerx Pharma
Analysis of all company metrics:vincerx.com, VINC
Manufactured product of Vincerx Pharma Inc.

The investment attractiveness of Vincerx Pharma, Inc. (VINC) within the oncology sector currently depends on the company's ability to preserve capital amid geopolitical risks that hinder clinical trials and reagent logistics. This metric reflects the net asset value per share, demonstrating the actual dynamics of assets; analyzing the book value per share curve allows for an assessment of the issuer's resilience to drawdowns and its long-term growth potential.

Competitor analysis for Vincerx Pharma, Inc.

TG Therapeutics Corp (TGTX) - Net Assets per Single Share|ACLX - Equity per Share|IRON (Disc Medicine, Inc.) - Book Value per Share|syndax.com (SNDX) - Accounting Value per Share|Book Value per Share KURA|Accounting Value per Share ADC Therapeutics S.A.|Book Value per Share FHTX|Book Value per Share VOR (Vor Bio Inc.)|NKTX - Net Assets per Single Share|Equity per Share Coeptis Therapeutics Inc. COEP|ATNM: Book Value per Share|ESLA - Accounting Value per Share|Book Value per Share CASI|MRKR (Marker Therapeutics, Inc.) - Net Asset Value per Share|INAB - Net Assets per Single Share|Accounting Value of a Share Eterna Therapeutics Inc (ERNA)|GT Biopharma (GTBP) - Accounting Value per Share|Accounting Value of a Share aptose.com (APTO)|Book Value per Share Bio-Path BPTH|MEI Pharma Corporation - Net Assets per Single Share